Showing results (101-110 of 163) with videos related to
Sort By:
Pageof 17
BMC Pregnancy and Childbirth|December 9, 2021
Cardiac dysfunction and remodeling regulated by anti-angiogenic environment in patients with preeclampsia: the ANGIOCOR prospective cohort study protocolJohana Ullmo, Monica Cruz-Lemini, Olga Sánchez-García, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 15, 2022
SCAI stage reclassification at 24 h predicts outcome of cardiogenic shock: Insights from the Altshock-2 registryNuccia Morici, Simone Frea, Maurizio Bertaina, et al.International Journal of Cardiology|August 26, 2020
Kinetics of procalcitonin, C-reactive protein and interleukin-6 in cardiogenic shock - Insights from the CardShock studyAnu Kataja, Tuukka Tarvasmäki, Johan Lassus, et al.Journal of Cardiovascular Development and Disease|June 25, 2025
Effect of DAPAgliflozin on Myocardial Fibrosis and Ventricular Function in Patients with ST-Segment Elevation Myocardial Infarction-DAPA-STEMI TrialLuis Ortega-Paz, Claudio Laudani, Alessandro Sionis, et al.Frontiers in Cardiovascular Medicine|September 25, 2025
Socioeconomic status and equity among patients with cardiogenic shockMarta Marcos-Mangas, Teresa López-Sobrino, Albert Ariza-Solé, et al.ESC Heart Failure|February 1, 2021
Mortality risk prediction in elderly patients with cardiogenic shock: results from the CardShock studyMari Hongisto, Johan Lassus, Tuukka Tarvasmäki, et al.European Heart Journal. Acute Cardiovascular Care|February 4, 2023
Quality indicators for post-resuscitation care after out-of-hospital cardiac arrest: a joint statement from the Association for Acute Cardiovascular Care of the European Society of Cardiology, the European Resuscitation Council, the European Society of Intensive Care Medicine, and the European Society for Emergency MedicineJohannes Grand, Francois Schiele, Christian Hassager, et al.Frontiers in Cardiovascular Medicine|December 8, 2025
Correction: Socioeconomic status and equity among patients with cardiogenic shockMarta Marcos-Mangas, Teresa López-Sobrino, Albert Ariza-Solé, et al.Journal of Clinical Medicine|June 12, 2026
Effect of Dapagliflozin on Myocardial Fibrosis After STEMI: A Double-Blind, Placebo-Controlled Randomized TrialLuis Ortega-Paz, Claudio Laudani, Carlos Igor Morr, et al.European Journal of Preventive Cardiology|April 22, 2026
Optimal lifelong roadmap post-ACS. A Clinical Consensus Statement of the European Association of Preventive Cardiology of the ESCRoberto F E Pedretti, Emeline Van Craenenbroeck, Christiaan Vrints, et al.Pageof 17